• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Avidity Biosciences Inc (NQ: RNA )

    48.51 +2.58 (+5.62%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,425,091
    Open 45.66
    Bid (Size) 48.50 (1)
    Ask (Size) 49.00 (13)
    Prev. Close 45.93
    Today's Range 45.16 - 48.63
    52wk Range 4.825 - 48.80
    Shares Outstanding 54,462,518
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Goldman Sachs Bullish On Avidity Biosciences, Cites Scalable RNA Therapeutics Platform For Rare Diseases
    Goldman Sachs has initiated coverage on Avidity Biosciences with a Buy rating and a $59 price target, citing multi-blockbuster commercial opportunities for its RNA therapeutics in muscular... 
    Via Benzinga
    Unveiling 7 Analyst Insights On Avidity Biosciences
    Via Benzinga

    Performance

    YTD
    +429.59%
    +429.59%
    1 Month
    +18.35%
    +18.35%
    3 Month
    +25.03%
    +25.03%
    6 Month
    +80.54%
    +80.54%
    1 Year
    +716.67%
    +716.67%

    More News

    Read More
    Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
    Via Benzinga
    Deep Dive Into Avidity Biosciences Stock: Analyst Perspectives (10 Ratings)
    Via Benzinga
    This Early-Stage Biotech Stock Is Up 400% — Should You Buy Now?
    Via MarketBeat
    The Analyst Landscape: 7 Takes On Avidity Biosciences
    Via Benzinga
    (RNA) - Analyzing Avidity Biosciences's Short Interest
    Via Benzinga
    Chart Of The Day: Avidity Biosciences - Something's Up?
    Via Talk Markets
    RNA Stock Earnings: Avidity Biosciences Beats EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    How Avidity Biosciences Just Dropped The Hammer On Sarepta Therapeutics
    Via Investor's Business Daily
    3 Stocks Doing Even Better Than Superstar Super Micro (SMCI)
    Via InvestorPlace
    3 Russell 2000 Growth Stocks That Could Be Worth the Risk
    Via The Motley Fool
    Topics Economy
    Exposures Interest Rates
    GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
    Via Benzinga
    Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
    Via Benzinga
    Topics ETFs
    Trading SMID Biotech Stocks In A Volatile Market
    Via Talk Markets
    Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio?
    Via Benzinga
    Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday
    Via Benzinga
    Crude Oil Moves Higher; Vera Bradley Shares Slide
    Via Benzinga
    Exposures Fossil Fuels
    Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Nasdaq Jumps 300 Points; Oracle Shares Spike Higher
    Via Benzinga
    Why Avidity Biosciences Shares Are Trading Higher Wednesday
    Via Benzinga
    Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    The 'Impressive' Results That Sent Top 1% Avidity Biosciences To A High Point
    Via Investor's Business Daily
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.